about
Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growthMacrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAEPost-transcriptional Regulation of NK Cell Activation.Fish Scale Collagen Peptides Protect against CoCl2/TNF-α-Induced Cytotoxicity and Inflammation via Inhibition of ROS, MAPK, and NF-κB Pathways in HaCaT CellsRon receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failurePotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesThe Effect of Lipopolysaccharide on Ischemic-Reperfusion Injury of Heart: A Double Hit Model of Myocardial Ischemia and Endotoxemia.HangAmDan-B, an ethnomedicinal herbal mixture, suppresses inflammatory responses by inhibiting Syk/NF-κB and JNK/ATF-2 pathways.Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's diseaseGenetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.Therapeutic antibodies that target inflammatory cytokines in autoimmune diseasesThe role of androgen and androgen receptor in skin-related disorders.Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.Transcriptional control of the TNF geneGenetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.The targets of curcumin.p38 MAPK Signaling in Pemphigus: Implications for Skin AutoimmunityMacrophages and inflammatory mediators in chemical toxicity: a battle of forces.Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation.
P2860
Q27300769-38C618FF-EFEF-4142-A96B-A87AA40E8F99Q28741374-16B1BE24-01C2-455D-8A83-6DA58B9E4264Q33631917-5CB98B3D-000B-4C9C-8401-7719F98CBE9BQ33876621-F45F8569-10C5-4BF3-A753-CA9756ED3BC7Q33916039-12485EDC-85EE-45A3-ADCF-43EC2A7712F9Q34594807-AC66D684-5C2F-4FFE-BBEC-52EF6E6EAE54Q36102258-3EA73C37-4D1A-4FFE-82A0-A7B6ADAF514FQ36533678-37AE212C-F841-47D9-A31F-7359D767552AQ36671837-5EFFBC36-1070-4709-93B3-8AF7A00DAE4EQ36839582-99E02127-D0B7-4D68-8C81-489771D4C2D2Q36924505-1C1EE874-21BE-4599-9261-C05BDAA5EC18Q36958902-5A79AFC6-5A8C-4EDE-AC9A-A16801BE16CCQ37149457-1B4A7615-EC51-4F87-A10A-120171FCF325Q37623769-D1AF694E-F772-4F56-975F-8003A4BF89C2Q37696067-525BB6C7-C163-4E53-B1B1-C84AA27B2B8CQ37725516-52B97AC0-4E24-46D0-A698-560EE4CB3FE8Q37800949-3E1A49B2-C02A-4A41-9CA0-78053E3BA081Q38128304-3B3DDEF2-190C-4F57-9BC9-85A1E8FA9CC0Q42134547-069DC804-8C4F-4805-9059-28253D54A924Q52627954-BF3DF49E-DB67-4AEE-88E1-6DC8DCAE7E0EQ53070035-DCEEDA13-EB64-41A4-9959-381746653472
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
TNF blockade: an inflammatory issue.
@ast
TNF blockade: an inflammatory issue.
@en
type
label
TNF blockade: an inflammatory issue.
@ast
TNF blockade: an inflammatory issue.
@en
prefLabel
TNF blockade: an inflammatory issue.
@ast
TNF blockade: an inflammatory issue.
@en
P2093
P356
P1476
TNF blockade: an inflammatory issue
@en
P2093
B B Aggarwal
D Jackson-Bernitsas
H Ichikawa
S Shishodia
P304
P356
10.1007/3-540-37673-9_10
P577
2006-01-01T00:00:00Z